Please use this identifier to cite or link to this item: https://doi.org/10.3945/jn.117.252981
DC FieldValue
dc.titleLipid-based nutrient supplements during pregnancy and lactation did not affect human milk oligosaccharides and bioactive proteins in a randomized trial
dc.contributor.authorJorgensen, J.M
dc.contributor.authorArnold, C
dc.contributor.authorAshorn, P
dc.contributor.authorAshorn, U
dc.contributor.authorChaima, D
dc.contributor.authorCheung, Y.B
dc.contributor.authorDavis, J.C.C
dc.contributor.authorFan, Y.-M
dc.contributor.authorGoonatilleke, E
dc.contributor.authorKortekangas, E
dc.contributor.authorKumwenda, C
dc.contributor.authorLebrilla, C.B
dc.contributor.authorMaleta, K
dc.contributor.authorTotten, S.M
dc.contributor.authorWu, L.D
dc.contributor.authorDewey, K.G
dc.date.accessioned2020-10-22T07:36:04Z
dc.date.available2020-10-22T07:36:04Z
dc.date.issued2017
dc.identifier.citationJorgensen, J.M, Arnold, C, Ashorn, P, Ashorn, U, Chaima, D, Cheung, Y.B, Davis, J.C.C, Fan, Y.-M, Goonatilleke, E, Kortekangas, E, Kumwenda, C, Lebrilla, C.B, Maleta, K, Totten, S.M, Wu, L.D, Dewey, K.G (2017). Lipid-based nutrient supplements during pregnancy and lactation did not affect human milk oligosaccharides and bioactive proteins in a randomized trial. Journal of Nutrition 147 (10) : 1867-1874. ScholarBank@NUS Repository. https://doi.org/10.3945/jn.117.252981
dc.identifier.issn00223166
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/179087
dc.description.abstractBackground: Human milk oligosaccharides (HMOs) and bioactive proteins are beneficial to infant health. Recent evidence suggests that maternal nutrition may affect the amount of HMOs and proteins in breast milk; however, the effect of nutrient supplementation on HMOs and bioactive proteins has not yet been well studied. Objective: We aimed to determine whether lipid-based nutrient supplements (LNSs) affect milk bioactive protein and HMO concentrations at 6 mo postpartum in women in rural Malawi. These are secondary outcomes of a previously published randomized controlled trial. Methods: Women were randomly assigned to consume either an iron and folic acid capsule (IFA) daily from #20 wk gestation until delivery, followed by placebo daily from delivery to 6 mo postpartum, or amultiplemicronutrient (MMN) capsule or LNS daily from ?20 wk gestation to 6 mo postpartum. Breast milk concentrations of total HMOs, sialylated HMOs, fucosylated HMOs, lactoferrin, lactalbumin, lysozymes, antitrypsin, immunoglobulin A, and osteopontin were analyzed at 6 mo postpartum (n = 647). Between-group differences in concentrations and in proportions of women classified as having low concentrations were tested. Results: HMO and bioactive protein concentrations did not differ between groups (P > 0.10 for all comparisons). At 6 mo postpartum, the proportions of women with low HMOs or bioactive proteins were not different between groups except for osteopontin. A lower proportion of women in the IFA group had low osteopontin compared with the LNS group after adjusting for covariates (OR: 0.5; 95% CI: 0.3, 0.9; P = 0.016). Conclusion: The study findings do not support the hypothesis that supplementation with an LNS or MMN capsule during pregnancy and postpartum would increase HMO or bioactive milk proteins at 6 mo postpartum among Malawian women. This trial was registered at clinicaltrials.gov as NCT01239693. © 2017 American Society for Nutrition.
dc.publisherAmerican Society for Nutrition
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceUnpaywall 20201031
dc.subjectbioactive protein
dc.subjectfolic acid
dc.subjectimmunoglobulin A
dc.subjectiron
dc.subjectlactalbumin
dc.subjectlactoferrin
dc.subjectlysozyme
dc.subjectmilk protein
dc.subjectoligosaccharide
dc.subjectosteopontin
dc.subjectplacebo
dc.subjecttrace element
dc.subjecttrypsin inhibitor
dc.subjectunclassified drug
dc.subjectadult
dc.subjectArticle
dc.subjectbreast milk
dc.subjectconcentration (parameters)
dc.subjectcontrolled study
dc.subjectdiet supplementation
dc.subjectdrug capsule
dc.subjectfemale
dc.subjectfucosylation
dc.subjectgestational age
dc.subjecthuman
dc.subjectlactation
dc.subjectlipid based nutrient supplement
dc.subjectmajor clinical study
dc.subjectMalawi
dc.subjectmaternal age
dc.subjectmaternal nutrition
dc.subjectnutritional status
dc.subjectobstetric delivery
dc.subjectoutcome assessment
dc.subjectparity
dc.subjectpregnancy
dc.subjectpregnant woman
dc.subjectprotein analysis
dc.subjectprotein quality
dc.subjectpuerperium
dc.subjectrandomized controlled trial
dc.subjectsecondary analysis
dc.subjectsialylation
dc.subjectsocial status
dc.typeArticle
dc.contributor.departmentDUKE-NUS MEDICAL SCHOOL
dc.description.doi10.3945/jn.117.252981
dc.description.sourcetitleJournal of Nutrition
dc.description.volume147
dc.description.issue10
dc.description.page1867-1874
dc.published.statePublished
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_3945_jn_117_252981.pdf698.37 kBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons